Brought to you by 
Oxford Asymmetry joins Pfizer's Pfizergen genomics network
02 Dec 1999
Executive Summary
Oxford Asymmetry Ltd. is one of four small biotech companies that Pfizer announced it will be collaborating with in a network of gene research alliances it calls Pfizergen.
Deal Industry
-
Pharmaceuticals
- Chiral Chemistry
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
- Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Concluded
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Oxford Asymmetry joins Pfizer's Pfizergen genomics network
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice